4-Bromo-2-furaldehyde

[ Density]:
1.7±0.1 g/cm3

[ Boiling Point ]:
225.0±20.0 °C at 760 mmHg

[ Melting Point ]:
54-58 °C

[ Molecular Formula ]:
C₅H₃BrO₂

[ Molecular Weight ]:
174.980

[ Flash Point ]:
89.9±21.8 °C

[ Exact Mass ]:
173.931641

[ PSA ]:
30.21000

[ LogP ]:
1.63

[ Vapour Pressure ]:
0.1±0.4 mmHg at 25°C

[ Index of Refraction ]:
1.573

[ Storage condition ]:
Refrigerator

Click to get detail MSDS

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H317-H319-H335

[ Precautionary Statements ]:
P261-P280-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ Hazard Codes ]:
Xn:Harmful;

[ Risk Phrases ]:
R22;R36/37/38;R43

[ Safety Phrases ]:
S26-S28-S36/37/39

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2932190090

Click to get detail synthetic route

[ HS Code ]: 2932190090

[ Summary ]:
2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.

Bioorg. Med. Chem. Lett. 17 , 3778, (2007)

A novel series of cyclobutenedione centered C(4)-alkyl substituted furanyl analogs was developed as potent CXCR2 and CXCR1 antagonists. Compound 16 exhibits potent inhibitory activities against IL-8 b...

More Articles